Chang-Godinich A, Ou R J, Koch D D
Cullen Eye Institute, Houston, Texas 77030, USA.
J Cataract Refract Surg. 1999 Sep;25(9):1226-31. doi: 10.1016/s0886-3350(99)00193-5.
To evaluate subjective functional visual improvement after phacoemulsification and intraocular lens (IOL) implantation and identify patient characteristics and treatment features associated with no functional improvement.
Academic referral practice, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.
A retrospective review was performed of the surgical results in 106 consecutive eyes of 102 patients who completed the American Society of Cataract and Refractive Surgery (ASCRS) Cataract Data Collection Form preoperatively and 1 month postoperatively. One surgeon performed all the surgery. The relationship of patient characteristics and treatment features and reported visual function was analyzed using an analysis of variance and the Wilcoxon rank sum and Fisher exact tests.
One month postoperatively, all patients demonstrated improved visual acuity. However, 15 patients (14%) reported unimproved or decreased visual function. No statistically significant intergroup difference (P > .05) was detected in mean preoperative, postoperative, and fellow eye best spectacle-corrected visual acuities or refractive errors; reported severity of preoperative symptoms or satisfaction with vision; reported preoperative daily activity functioning or prevalence of hypertension and diabetes; type of anesthesia, lens material, or wound closure used; intraoperative or postoperative complication rates. However, patients reporting unimproved vision tended to be older and less satisfied with their quality of life and medical care than those reporting improved vision (P = .02, .03, .01, respectively).
Self-reported visual function generally improved after phacoemulsification and IOL implantation; however, some older patients less satisfied with their quality of life and medical care reported no functional improvement despite improved visual acuity. These patients might benefit from an extended preoperative discussion of postoperative expectations.
评估白内障超声乳化吸除联合人工晶状体(IOL)植入术后主观功能性视力改善情况,并确定与无功能改善相关的患者特征和治疗特点。
美国得克萨斯州休斯敦贝勒医学院眼科系卡伦眼科研究所的学术转诊机构。
对102例患者的106只连续眼睛的手术结果进行回顾性分析,这些患者术前和术后1个月均填写了美国白内障与屈光手术学会(ASCRS)白内障数据收集表。所有手术均由一名外科医生完成。使用方差分析、Wilcoxon秩和检验和Fisher精确检验分析患者特征、治疗特点与报告的视觉功能之间的关系。
术后1个月,所有患者的视力均有改善。然而,15例患者(14%)报告视觉功能未改善或下降。在术前、术后及对侧眼最佳矫正视力或屈光不正的平均水平;术前症状的报告严重程度或对视力的满意度;术前日常活动功能的报告或高血压和糖尿病的患病率;麻醉类型、晶状体材料或伤口闭合方式;术中或术后并发症发生率方面,未检测到组间有统计学意义的差异(P>.05)。然而,与报告视力改善的患者相比,报告视力未改善的患者往往年龄较大,对生活质量和医疗护理的满意度较低(分别为P =.02、.03、.01)。
白内障超声乳化吸除联合IOL植入术后,自我报告的视觉功能总体上有所改善;然而,一些对生活质量和医疗护理不太满意的老年患者尽管视力有所提高,但报告视觉功能未改善。这些患者可能会从术前对术后预期进行更深入的讨论中受益。